— Know what they know.
Not Investment Advice

ANAB NASDAQ

AnaptysBio, Inc.
1W: -4.8% 1M: -13.1% 3M: -22.1% YTD: +61.9% 1Y: +127.7% 3Y: +294.2% 5Y: +166.2%
$48.53
-0.10 (-0.21%)
 
Weekly Expected Move ±3.8%
$45 $47 $49 $50 $52
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $1.4B mcap · 28M float · 2.13% daily turnover · Short 51% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
44.4 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 466.0%
Cost Advantage ★
59
Intangibles
51
Switching Cost
29
Network Effect
57
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ANAB shows a Weak competitive edge (44.4/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 466.0% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$81
Low
$88
Avg Target
$95
High
Based on 2 analysts since Sep 21, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 6Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$81.00
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-23 Leerink Partners — $90 $81 -9 +59.9% $50.67
2026-09-22 H.C. Wainwright Joseph Pantginis $66 $95 +29 +73.0% $54.92
2026-08-31 Wolfe Research Andy Chen $25 $78 +53 +38.6% $56.28
2026-08-25 Scotiabank — Initiated $70 — +19.8% $58.44
2026-05-15 Leerink Partners — $85 $90 +5 +43.7% $62.65
2026-05-13 UBS — $60 $76 +16 +15.9% $65.58
2026-05-13 Barclays — $55 $75 +20 +14.4% $65.58
2026-04-28 Leerink Partners — $45 $85 +40 +27.6% $66.59
2026-04-21 UBS — $70 $60 -10 +10.6% $54.23
2026-03-06 Truist Financial John Lee $36 $50 +14 -11.2% $56.29
2026-03-05 Stifel Nicolaus Alex Thompson $56 $85 +29 +48.2% $57.36
2026-03-04 H.C. Wainwright Emily Bodnar $59 $66 +7 +13.7% $58.03
2026-01-07 UBS Michael Yee Initiated $70 — +59.4% $43.91
2025-12-18 Guggenheim — $54 $140 +86 +202.8% $46.23
2025-12-17 Barclays Etzer Darout $70 $55 -15 +22.1% $45.03
2025-12-11 Stifel Nicolaus — $80 $56 -24 +24.6% $44.95
2025-11-11 Barclays — $78 $70 -8 +106.0% $33.98
2025-11-10 Wedbush David Nierengarten $70 $50 -20 +50.3% $33.26
2025-11-10 Truist Financial Joon Lee $30 $36 +6 +5.0% $34.28
2025-10-29 Stifel Nicolaus — Initiated $80 — +121.2% $36.16
2025-10-15 Wedbush David Nierengarten Initiated $70 — +119.8% $31.85
2025-10-13 Barclays — Initiated $78 — +148.6% $31.37
2025-09-30 H.C. Wainwright — $19 $59 +40 +153.5% $23.27
2025-05-06 Guggenheim Yatin Suneja $52 $54 +2 +168.4% $20.12
2025-03-03 Guggenheim — $90 $52 -38 +255.2% $14.64
2025-02-03 Wolfe Research Andy Chen Initiated $25 — +50.1% $16.66
2024-12-11 H.C. Wainwright Emily Bodnar $52 $19 -33 +22.5% $15.51
2024-11-06 H.C. Wainwright Emily Bodnar Initiated $52 — +168.3% $19.38
2024-11-06 Leerink Partners David Risinger $47 $45 -2 +132.2% $19.38
2024-10-21 Guggenheim Yatin Suneja Initiated $90 — +157.3% $34.98
2024-10-15 Piper Sandler Yasmeen Rahimi Initiated $80 — +130.3% $34.74
2024-10-03 New Street David Risinger Initiated $35 — -0.6% $35.22
2024-08-15 Truist Financial Joon Lee Initiated $30 — -13.4% $34.65
2024-04-16 Leerink Partners David Risinger Initiated $47 — +121.0% $21.27
2022-11-18 J.P. Morgan — Initiated $32 — +9.7% $29.16

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
Oct 02, 2026
DCF
1
ROE
5
ROA
5
D/E
1
P/E
3
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ANAB receives an overall rating of B. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 B- B
2026-09-22 D+ B-
2026-03-03 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 57 Grade D
Profitability
80
Balance Sheet
49
Earnings Quality
14
Growth
88
Value
65
Momentum
63
Safety
100
Cash Flow
33
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ANAB scores highest in Safety (100/100) and lowest in Earnings Quality (14/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
4.22
Safe Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✗ ✗ ✗ ✗ ✓ ✓
Beneish M-Score
0.82
Possible Manipulator
Ohlson O-Score
-6.27
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB
Score: 59.2/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.09x
Accruals: 54.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ANAB scores 4.22, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ANAB scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ANAB's score of 0.82 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ANAB's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ANAB receives an estimated rating of BBB (score: 59.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ANAB's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
7.19x
PEG
-0.00x
P/S
6.05x
P/B
134.17x
P/FCF
134.39x
P/OCF
134.29x
EV/EBITDA
27.68x
EV/Revenue
10.66x
EV/EBIT
28.24x
EV/FCF
140.23x
Earnings Yield
8.06%
FCF Yield
0.74%
Shareholder Yield
0.54%
Graham Number
$6.00
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 7.2x earnings, ANAB trades at a deep value multiple. An earnings yield of 8.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $6.00 per share, 709% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
3.278
NI / EBT
×
Interest Burden
0.666
EBT / EBIT
×
EBIT Margin
0.378
EBIT / Rev
×
Asset Turnover
0.729
Rev / Assets
×
Equity Multiplier
-19.100
Assets / Equity
=
ROE
-1146.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ANAB's ROE of -1146.3% is driven by Asset Turnover (0.729), indicating efficient use of assets to generate revenue. A tax burden ratio of 3.28 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$46.24
Price/Value
1.46x
Margin of Safety
-45.96%
Premium
45.96%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ANAB's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ANAB trades at a 46% premium to its adjusted intrinsic value of $46.24, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 7.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$48.53
Median 1Y
$36.61
5th Pctile
$9.71
95th Pctile
$138.87
Ann. Volatility
81.9%
Analyst Target
$81.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Daniel Faga
President and Chief Executive Officer and Director
$706,011 $1,592,001 $6,133,943
Paul Lizzul Medical
edical Officer
$545,754 $505,703 $2,365,377
Dennis Mulroy Financial
ancial Officer
$510,070 $397,444 $2,007,927

CEO Pay Ratio

13:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,133,943
Avg Employee Cost (SGA/emp): $487,856
Employees: 104

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
104
-23.5% YoY
Revenue / Employee
$2,255,798
Rev: $234,603,000
Profit / Employee
$-127,231
NI: $-13,232,000
SGA / Employee
$487,856
Avg labor cost proxy
R&D / Employee
$1,307,404
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 2.3% -15.3% -21.3% -31.3% -40.8% -41.6% -52.4% -63.6% -74.3% -93.4% -1.4% -2.1% -1.6% -1.8% -3.4% 7.6% -3.1% -24.5% -1.1% -11.5% -11.46%
ROA 2.1% -10.9% -14.9% -21.0% -25.9% -20.5% -23.2% -25.7% -26.7% -30.8% -34.1% -36.0% -33.8% -31.0% -34.0% -34.8% -20.0% -3.1% -7.1% 60.0% 60.02%
ROIC 25.2% 26.3% 35.9% 65.5% 65.3% 57.0% 45.7% 42.2% 42.7% 45.6% -6.2% 39.6% 35.4% -1.7% 27.3% 23.0% -33.3% -14.5% 8.8% 4.7% 4.66%
ROCE 2.1% -9.2% -11.7% -16.7% -19.7% -18.4% -22.5% -26.3% -29.1% -34.5% -37.7% -36.4% -27.9% -21.7% -20.8% -20.7% -2.2% 20.5% 19.5% 31.9% 31.86%
Gross Margin -6.4% -25.5% -22.2% -16.1% -16.1% -2.4% -24.4% -8.5% -8.3% -2.7% -4.2% -2.8% -40.6% 1.2% -48.3% -69.9% 58.8% 2.0% 97.6% 1.1% 1.10%
Operating Margin -32.4% -30.8% -32.7% -22.9% -22.9% -3.8% -32.3% -11.6% -11.4% -4.7% -5.9% -3.7% -75.8% -22.4% -99.2% -1.2% 45.5% 61.8% -1.4% 2.4% 2.44%
Net Margin -31.9% -32.2% -37.4% -26.8% -25.9% -3.9% -32.2% -11.5% -11.2% -4.7% -6.1% -4.3% -1.1% -50.5% -1.4% -1.7% 19.8% 45.8% -2.1% 6.7% 6.69%
EBITDA Margin -28.7% -31.8% -31.8% -21.5% -20.7% -3.2% -28.6% -10.1% -9.7% -3.8% -5.2% -3.2% -56.1% -8.8% -74.2% -82.6% 50.1% 64.7% -1.2% 53.4% 53.40%
FCF Margin 12.5% -74.8% -84.8% -3.2% -19.7% -7.2% -7.3% -6.1% -6.5% -7.1% -5.8% -4.3% -1.8% -1.5% -97.6% -1.0% -85.8% 8.4% 1.9% 7.6% 7.60%
OCF Margin 13.9% -72.7% -82.7% -3.2% -19.6% -7.2% -7.2% -6.1% -6.5% -7.0% -5.8% -4.2% -1.8% -1.5% -97.2% -1.0% -85.5% 8.4% 1.9% 7.6% 7.61%
ROA 3Y Avg snapshot only -5.87%
ROIC Economic snapshot only 1.96%
Cash ROA snapshot only 5.70%
Cash ROIC snapshot only 15.58%
CROIC snapshot only 15.57%
NOPAT Margin snapshot only 2.28%
Pretax Margin snapshot only 25.13%
R&D / Revenue snapshot only 39.36%
SGA / Revenue snapshot only 28.72%
SBC / Revenue snapshot only 10.94%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 59.14 -11.04 -6.02 -3.53 -3.57 -4.57 -2.97 -2.51 -2.15 -2.32 -2.46 -2.69 -3.89 -1.85 -2.70 -3.22 -7.00 -76.56 -39.60 12.41 7.190
P/S Ratio 4.06 10.10 8.64 15.84 107.17 57.13 37.94 27.92 21.24 22.13 17.52 15.00 11.28 2.95 3.39 3.46 3.49 4.32 4.56 10.22 6.047
P/B Ratio 1.29 1.79 1.38 1.25 1.73 2.24 2.12 2.43 2.64 4.31 8.42 46.27 7.65 3.79 11.16 -9.53 -20.13 27.22 83.21 229.41 134.169
P/FCF 32.43 -13.49 -10.19 -4.91 -5.44 -7.95 -5.23 -4.57 -3.25 -3.12 -3.00 -3.52 -6.24 -1.98 -3.48 -3.33 -4.08 51.66 240.58 134.39 134.391
P/OCF 29.25 — — — — — — — — — — — — — — — — 51.43 236.87 134.29 134.294
EV/EBITDA 13.96 -1.99 0.41 0.42 -0.50 -1.58 0.06 0.41 0.60 -0.05 -2.70 -0.89 -1.87 -2.73 -0.72 -2.95 -150.93 10.33 17.98 27.68 27.675
EV/Revenue 1.17 1.75 -0.53 -1.67 12.93 16.13 -0.61 -3.85 -5.15 0.38 16.34 4.04 4.05 2.77 0.49 1.43 4.07 3.05 4.53 10.66 10.663
EV/EBIT 17.04 -1.92 0.39 0.41 -0.49 -1.54 0.06 0.40 0.59 -0.05 -2.67 -0.87 -1.84 -2.66 -0.70 -2.83 -98.71 10.71 18.76 28.24 28.240
EV/FCF 9.34 -2.34 0.63 0.52 -0.66 -2.24 0.08 0.63 0.79 -0.05 -2.80 -0.95 -2.24 -1.86 -0.51 -1.37 -4.75 36.49 238.51 140.23 140.227
Earnings Yield 1.7% -9.1% -16.6% -28.3% -28.0% -21.9% -33.7% -39.9% -46.5% -43.1% -40.6% -37.2% -25.7% -54.0% -37.0% -31.1% -14.3% -1.3% -2.5% 8.1% 8.06%
FCF Yield 3.1% -7.4% -9.8% -20.4% -18.4% -12.6% -19.1% -21.9% -30.8% -32.0% -33.3% -28.4% -16.0% -50.5% -28.7% -30.0% -24.5% 1.9% 0.4% 0.7% 0.74%
Price/Tangible Book snapshot only 229.411
EV/OCF snapshot only 140.126
EV/Gross Profit snapshot only 8.011
Acquirers Multiple snapshot only 18.919
Shareholder Yield snapshot only 0.54%
Graham Number snapshot only $6.00
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 18.51 34.40 25.90 22.79 21.39 17.16 12.21 10.53 10.92 10.87 11.53 9.09 10.23 9.51 8.25 8.22 8.68 9.07 7.58 5.61 5.613
Quick Ratio 18.51 34.40 25.90 22.79 21.39 17.16 12.21 10.53 10.92 10.87 11.53 9.09 10.23 9.51 8.25 8.22 8.68 9.07 7.58 5.61 5.613
Debt/Equity 0.05 0.06 0.06 0.07 0.07 0.07 0.10 0.13 0.15 0.20 6.86 1.72 0.20 5.21 0.46 -0.34 -11.78 0.38 21.76 25.47 25.469
Net Debt/Equity -0.92 -1.48 -1.47 -1.39 -1.52 -1.61 -2.16 -2.77 -3.28 -4.23 -0.57 -33.79 -4.90 -0.22 -9.53 — — -8.00 -0.71 9.96 9.962
Debt/Assets 0.05 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.81 0.04 0.03 0.76 0.04 0.05 0.98 0.04 0.84 0.85 0.850
Debt/EBITDA 2.05 -0.38 -0.30 -0.21 -0.17 -0.18 -0.17 -0.15 -0.14 -0.13 -2.36 -0.12 -0.13 -3.98 -0.20 -0.25 -75.81 0.20 4.74 2.94 2.945
Net Debt/EBITDA -34.50 9.46 7.08 4.44 3.65 4.01 3.62 3.35 3.08 2.64 0.20 2.40 3.35 0.17 4.25 4.20 -21.33 -4.30 -0.16 1.15 1.152
Interest Coverage — — -14.63 -9.07 -7.00 -5.10 -5.64 -6.55 -7.51 -7.91 -7.02 -5.29 -3.34 -1.90 -1.27 -0.88 -0.09 0.84 0.68 1.08 1.076
Equity Multiplier 1.11 1.80 1.89 1.98 2.23 2.33 2.89 3.48 4.05 5.13 8.49 43.26 5.85 6.83 12.41 -7.49 -12.00 9.79 25.86 29.95 29.947
Cash Ratio snapshot only 4.643
Debt Service Coverage snapshot only 1.098
Cash to Debt snapshot only 0.609
FCF to Debt snapshot only 0.067
Defensive Interval snapshot only 311.0 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.30 0.12 0.10 0.05 0.01 0.02 0.02 0.02 0.03 0.03 0.05 0.06 0.12 0.19 0.27 0.32 0.40 0.55 0.62 0.73 0.729
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 321.06 144.24 48.80 28.76 4.63 8.96 8.75 6.14 6.73 4.15 5.33 5.00 7.39 3.83 8.96 8.10 3.86 6.29 10.65 10.10 10.100
Payables Turnover 16.66 33.06 39.26 32.46 21.14 39.25 35.84 35.70 25.64 35.36 34.68 29.73 30.61 37.66 31.38 39.86 47.19 0.62 -5.59 -20.37 —
DSO 1 3 7 13 79 41 42 59 54 88 68 73 49 95 41 45 95 58 34 36 36.1 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 — — —
DPO 22 11 9 11 17 9 10 10 14 10 11 12 12 10 12 9 8 593 — — —
Cash Conversion Cycle -21 -9 -2 1 62 31 32 49 40 78 58 61 37 86 29 36 87 -535 — — —
Fixed Asset Turnover snapshot only 20.375
Cash Velocity snapshot only 1.448
Capital Intensity snapshot only 1.334
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 5.8% -15.8% -25.8% -76.2% -96.3% -83.7% -79.8% -46.3% 2.3% 66.8% 1.1% 1.4% 2.8% 4.3% 3.9% 3.0% 2.0% 1.6% 1.1% 92.9% 92.92%
Net Income 1.1% -1.9% -1.5% -11.4% -17.1% -1.2% -80.2% -33.3% -9.6% -27.1% -19.4% -18.1% -12.1% 11.2% 13.9% 22.1% 48.9% 90.9% 81.0% 2.5% 2.48%
EPS 1.1% -1.9% -1.5% -11.0% -16.6% -1.2% -78.6% -41.2% -16.8% -36.0% -24.6% -15.0% -3.0% 22.5% 24.7% 26.0% 49.1% 91.1% 79.7% 2.2% 2.18%
FCF 1.2% -2.2% -94.5% -15.5% -6.8% -56.4% -73.1% -1.6% -10.7% -64.4% -72.8% -64.4% -5.7% -11.6% 18.6% 1.4% -40.6% 1.1% 1.0% 1.1% 1.14%
EBITDA 1.1% -1.9% -1.3% -11.9% -12.3% -89.0% -66.1% -28.9% -10.5% -34.1% -22.0% -13.5% 3.5% 34.3% 45.0% 57.1% 96.3% 1.7% 1.8% 2.5% 2.53%
Op. Income 1.1% -1.4% -1.2% -8.9% -16.7% -1.0% -82.1% -43.8% -23.2% -42.8% -26.9% -15.9% 0.6% 30.1% 38.2% 47.0% 80.5% 1.4% 1.4% 2.6% 2.55%
OCF Growth snapshot only 1.14%
Asset Growth snapshot only -5.45%
Debt Growth snapshot only 16.86%
Shares Change snapshot only 24.87%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 1.5% 1.3% 1.2% 34.0% -3.5% 8.7% -22.5% -10.4% -6.0% -38.8% -31.4% -33.0% -22.4% 13.1% 28.4% 72.3% 2.4% 1.8% 1.8% 1.6% 1.64%
Revenue 5Y — — — 28.0% -8.5% 0.6% 1.3% 33.9% 13.3% 28.0% 35.6% 25.0% 62.8% 62.7% 37.2% 46.9% 56.6% 25.6% 26.7% 18.6% 18.60%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — 97.0% 96.98%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — 27.5% 27.45%
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — 21.1% 21.07%
Assets 3Y -6.7% 8.1% 8.1% 7.9% 11.1% 11.9% 9.2% 8.8% 8.2% 2.8% 0.8% 0.1% 5.2% -9.0% -12.3% -17.8% -17.0% -15.8% -15.8% -15.1% -15.05%
Assets 5Y — — 36.7% 35.9% 38.4% 13.1% 11.9% 11.1% -1.4% -2.3% -3.9% -2.3% 1.8% 2.1% -0.1% -3.6% -1.7% -2.6% -3.6% -5.8% -5.77%
Equity 3Y -8.4% -9.8% -10.9% -12.1% -13.0% -13.5% -21.9% -27.0% -30.6% -39.4% -50.0% -70.5% -39.6% -41.6% -53.1% — — -47.8% -59.4% -58.5% -58.53%
Book Value 3Y -12.3% -10.7% -11.7% -13.4% -14.2% -14.8% -22.5% -26.4% -29.9% -38.4% -49.6% -70.5% -40.7% -43.6% -54.7% — — -49.5% -59.8% -62.5% -62.49%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.67 0.73 0.73 0.25 0.12 0.10 0.07 0.03 0.00 0.00 0.00 0.01 0.01 0.27 0.29 0.46 0.55 0.35 0.41 0.31 0.310
Earnings Stability 0.03 0.01 0.35 0.24 0.14 0.28 0.44 0.33 0.24 0.43 0.56 0.49 0.37 0.52 0.63 0.53 0.24 0.05 0.03 0.13 0.128
Margin Stability 0.00 0.00 0.00 0.07 0.00 0.00 0.00 0.14 0.00 0.11 0.04 0.24 0.01 0.14 0.09 0.28 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.20 0.50 0.50 0.50 0.20 0.50 0.50 0.87 0.50 0.89 0.92 0.93 0.95 0.96 0.94 0.91 0.80 0.50 0.50 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.24 -0.02 -0.09 -0.24 -0.39 -0.38 -0.56 -0.78 -1.00 -1.53 -2.95 -16.56 -1.11 -0.88 -2.07 — — 1.60 1.67 — —
Gross Margin Trend 10.84 5.18 0.92 -0.88 -17.93 -7.32 -7.97 -6.40 2.49 -2.61 -0.20 1.59 11.64 6.38 6.16 5.40 4.53 4.74 3.84 3.35 3.350
FCF Margin Trend 8.70 3.74 0.82 -1.22 -17.87 -6.72 -6.68 -4.52 3.24 -3.12 -1.79 0.41 11.31 5.65 5.58 4.15 3.32 4.37 3.43 2.73 2.727
Sustainable Growth Rate 2.3% — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate 2.1% — — — — — — — — — — — — — — — — — — 1.5% 1.50%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.02 0.79 0.58 0.72 0.65 0.57 0.56 0.54 0.66 0.74 0.82 0.76 0.62 0.93 0.77 0.96 1.71 -1.49 -0.17 0.09 0.092
FCF/OCF 0.90 1.03 1.03 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 1.00 0.999
FCF/Net Income snapshot only 0.092
OCF/EBITDA snapshot only 0.198
CapEx/Revenue 1.4% 2.2% 2.1% 1.3% 4.4% 3.5% 4.5% 4.6% 4.7% 4.7% 2.9% 1.6% 0.7% 0.4% 0.3% 0.3% 0.2% 0.0% 0.0% 0.0% 0.01%
CapEx/Depreciation snapshot only 0.007
Accruals Ratio -0.02 -0.02 -0.06 -0.06 -0.09 -0.09 -0.10 -0.12 -0.09 -0.08 -0.06 -0.09 -0.13 -0.02 -0.08 -0.01 0.14 -0.08 -0.08 0.54 0.545
Sloan Accruals snapshot only -0.292
Cash Flow Adequacy snapshot only 1390.923
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% — — — — — — — — — — — — — — — — — — 0.0% 0.00%
FCF Payout Ratio 0.0% — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% — — — — — — — — — — — — — — — — — — 6.7% 6.70%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 9.3% 13.8% 15.7% 13.2% 3.1% 0.0% 0.0% 0.2% 1.3% 13.1% 11.1% 6.8% 6.1% 0.5% 0.54%
Net Buyback Yield -0.2% -0.2% -1.2% -1.6% -1.7% -2.0% 7.2% 11.6% 14.0% 12.5% 2.6% -0.5% -15.6% -37.3% -25.1% -10.5% 10.7% 5.4% 3.4% -1.0% -1.02%
Total Shareholder Return -0.2% -0.2% -1.2% -1.6% -1.7% -2.0% 7.2% 11.6% 14.0% 12.5% 2.6% -0.5% -15.6% -37.3% -25.1% -10.5% 10.7% 5.4% 3.4% -1.0% -1.02%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 3.28 3.278
Interest Burden (EBT/EBIT) 1.00 1.00 1.07 1.11 1.14 1.20 1.18 1.15 1.13 1.14 1.16 1.21 1.32 1.53 1.78 2.14 12.10 -0.20 -0.47 0.67 0.666
EBIT Margin 0.07 -0.91 -1.34 -4.04 -26.28 -10.46 -10.86 -9.66 -8.72 -8.34 -6.13 -4.63 -2.20 -1.04 -0.70 -0.50 -0.04 0.28 0.24 0.38 0.378
Asset Turnover 0.30 0.12 0.10 0.05 0.01 0.02 0.02 0.02 0.03 0.03 0.05 0.06 0.12 0.19 0.27 0.32 0.40 0.55 0.62 0.73 0.729
Equity Multiplier 1.09 1.41 1.43 1.49 1.58 2.03 2.26 2.48 2.78 3.03 4.01 5.97 4.79 5.89 10.12 -21.88 15.40 7.85 16.07 -19.10 -19.100
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.31 $-2.10 $-2.74 $-3.83 $-4.77 $-4.53 $-4.89 $-5.41 $-5.57 $-6.15 $-6.09 $-6.22 $-5.73 $-4.77 $-4.59 $-4.60 $-2.92 $-0.42 $-0.93 $5.44 $5.44
Book Value/Share $13.98 $12.95 $11.93 $10.79 $9.81 $9.21 $6.84 $5.57 $4.53 $3.31 $1.78 $0.36 $2.92 $2.33 $1.11 $-1.55 $-1.01 $1.19 $0.44 $0.29 $0.36
Tangible Book/Share $13.98 $12.95 $11.93 $10.79 $9.81 $9.21 $6.84 $5.57 $4.53 $3.31 $1.78 $0.36 $2.92 $2.33 $1.11 $-1.55 $-1.01 $1.19 $0.44 $0.29 $0.29
Revenue/Share $4.45 $2.29 $1.91 $0.85 $0.16 $0.36 $0.38 $0.49 $0.56 $0.65 $0.86 $1.11 $1.98 $3.00 $3.65 $4.28 $5.84 $7.49 $8.10 $6.60 $8.12
FCF/Share $0.56 $-1.72 $-1.62 $-2.76 $-3.13 $-2.60 $-2.78 $-2.97 $-3.69 $-4.57 $-5.01 $-4.75 $-3.58 $-4.46 $-3.56 $-4.45 $-5.01 $0.63 $0.15 $0.50 $0.62
OCF/Share $0.62 $-1.67 $-1.58 $-2.75 $-3.12 $-2.59 $-2.76 $-2.94 $-3.66 $-4.54 $-4.98 $-4.73 $-3.57 $-4.44 $-3.55 $-4.43 $-5.00 $0.63 $0.16 $0.50 $0.62
Cash/Share $13.63 $19.91 $18.24 $15.68 $15.66 $15.51 $15.42 $16.13 $15.56 $14.70 $13.23 $12.82 $14.89 $12.66 $11.09 $9.22 $8.58 $9.94 $9.98 $4.56 $5.61
EBITDA/Share $0.37 $-2.02 $-2.47 $-3.37 $-4.10 $-3.70 $-4.07 $-4.60 $-4.82 $-5.31 $-5.18 $-5.08 $-4.28 $-3.05 $-2.49 $-2.07 $-0.16 $2.21 $2.04 $2.54 $2.54
Debt/Share $0.76 $0.76 $0.74 $0.72 $0.70 $0.68 $0.68 $0.70 $0.69 $0.67 $12.22 $0.62 $0.57 $12.13 $0.51 $0.52 $11.94 $0.45 $9.67 $7.49 $7.49
Net Debt/Share $-12.87 $-19.15 $-17.50 $-14.96 $-14.96 $-14.83 $-14.74 $-15.43 $-14.87 $-14.03 $-1.01 $-12.20 $-14.32 $-0.52 $-10.58 $-8.70 $3.36 $-9.49 $-0.32 $2.93 $2.93
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 4.223
Altman Z-Prime snapshot only 7.000
Piotroski F-Score 6 3 1 3 3 3 1 3 4 3 4 3 4 4 5 4 3 6 6 5 5
Beneish M-Score — -13.93 3.34 31.25 15.91 7.13 -2.49 -1.03 -1.26 -0.64 3.12 -0.02 13.86 -117.54 4.22 0.06 -0.14 -3.14 -3.93 0.82 0.823
Ohlson O-Score snapshot only -6.273
ROIC (Greenblatt) snapshot only 51.35%
Net-Net WC snapshot only $-3.00
EVA snapshot only $529095162.86
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BBB
Credit Score 89.81 49.98 36.98 37.61 38.28 38.92 33.15 33.10 33.54 31.97 22.89 27.14 32.89 22.47 31.43 20.00 20.00 47.30 24.87 59.20 59.197
Credit Grade snapshot only 9
Credit Trend snapshot only 39.197
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 54
Sector Credit Rank snapshot only 52

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms